Amrize (AMRZ) Crashes to 52-Week Low on Earnings Miss and EBITDA Guide Cut
Amrize Ltd closed at $46.64 on Monday, down 8.94 percent, as Q2 earnings disappointment and a lowered EBITDA outlook sent the stock tumbling to its lowest level in 52 weeks. Trading volume surged to 9.12 million shares, nearly triple the 3.14 million average, according to Yahoo Finance, signaling aggressive distribution rather than a liquidity-driven pullback.
The 52-week low of $46.31 briefly flashed on the tape before a partial after-hours recovery to $46.84. The question now is whether this marks a technical blow-off or an overreaction that sets up a mean-reversion bounce off the annual floor.
Why This Setup Matters Now
AMRZ appeared on the Yahoo Finance day losers screen as the hardest-hit stock among qualified candidates, with a near 9 percent decline on elevated volume. The stock is now touching the bottom of its entire 52-week trading range, a level that has drawn attention from both breakdown traders and contrarian buyers.
| Field | Detail |
|---|---|
| Ticker | AMRZ (Amrize Ltd) |
| Close Price | $46.64 |
| Daily Change | -8.94% (-$4.58) |
| Volume | 9.12M (avg 3.14M) |
| Day Range | $46.31 - $48.78 |
| 52-Week Range | $46.31 - $65.94 |
| P/E (TTM) | 22.32 |
| Beta | 0.75 |
| Analyst Mean Target | $61.83 |
| Analyst High Target | $70.00 |
| Monthly Change | -20.15% |
| YTD Change | +14.30% |
| Source | Yahoo Finance - AMRZ |
Quick Read
| Question | Answer |
|---|---|
| What happened | Q2 profit miss and EBITDA guidance cut triggered a sharp selloff |
| Key technical event | Stock hit 52-week low of $46.31, breaking below prior support |
| Volume context | 2.9x average volume confirms conviction selling |
| Analyst backdrop | Wall Street mean target of $61.83 implies ~33% upside from current levels |
| Near-term bias | Bearish breakdown, but 52-week low can draw mean-reversion attempts |
Technical Bias
| Factor | Signal | Weight |
|---|---|---|
| Price vs 52-week range | At absolute low ($46.31) | Bearish |
| Volume | 2.9x average on down day | Bearish |
| Momentum (technical rating) | Strong sell signal across daily, weekly, and monthly timeframes | Bearish |
| Monthly trend | -20.15% decline over the past month | Bearish |
| Analyst price target | Mean $61.83, ~33% above current price | Bullish counterweight |
| Acquisition catalyst | Rapid Redi-Mix deal in Dallas-Fort Worth | Mildly bullish |
| Beta | 0.75, less volatile than market | Neutral |
| YTD performance | +14.30% year-to-date | Neutral |
Overall Bias: Bearish in the near term. Five of eight factors lean negative. The analyst target and acquisition activity provide a floor narrative, but the technicals show no signs of stabilization.
Key Levels To Watch
| Level | Price Zone | Type | Significance |
|---|---|---|---|
| Resistance 2 | $65.94 | 52-week high | Full-range recovery target; not confirmed support if tested from below |
| Resistance 1 | $58 - $60 | Derived zone | Round-number area below the 52-week high; prior consolidation region |
| Pivot | $46.64 | Current close | Intraday close level; must hold for any bounce attempt |
| Support 1 | $46.31 | 52-week low | Fresh low; first test of breakout vs bounce hinges here |
| Support 2 | $44 - $45 | Derived zone | Round-number zone below 52-week low if breakdown continues |
Note: Resistance 1 and Support 2 are derived zones based on round-number levels and prior price structure. They have not been confirmed as historical support or resistance on intraday charts.
Scenario Map
| Scenario | Trigger | Target Zone | Probability |
|---|---|---|---|
| Bullish reversal | Daily close above $48.78 (intraday high) on above-average volume | $52 - $55 derived zone | Low |
| Range-bound bounce | Rejection off $46.31 low, consolidation in $46-$48 band | $48.78 - $50 | Moderate |
| Bearish continuation | Follow-through close below $46.31 on elevated volume | $44 - $45 derived zone | High |
| Deep breakdown | Gap-down open below $44 on negative follow-up news | Below $40 | Low |
Momentum And Volume Check
| Metric | Value | Interpretation |
|---|---|---|
| Daily volume | 9.12M shares | 2.9x the average; confirms selling conviction |
| Average volume | 3.14M shares | Baseline for comparison |
| Volume ratio | 2.9x | Above 2x threshold; distribution day |
| Price change | -8.94% | Sharp decline on high volume; bearish divergence |
| Monthly change | -20.15% | Extended monthly downtrend |
| Technical rating (daily) | Strong Sell | Per Yahoo Finance technical rating |
| Technical rating (weekly) | Strong Sell | Consistent across timeframes |
| Technical rating (monthly) | Strong Sell | Multi-timeframe bearish alignment |
The volume profile on this decline is concerning. A 2.9x volume spike on an almost 9 percent down day points to institutional distribution rather than retail panic. The strong-sell rating across all three timeframes on Yahoo Finance indicates momentum indicators such as RSI and MACD are deeply oversold, which can sometimes precede short-term mean-reversion bounces -- but also confirms the downtrend has no visible inflection.

What Would Change The View
| Condition | Direction | Impact |
|---|---|---|
| Daily close above $48.78 on above-average volume | Bullish | Reclaims intraday high; negates breakdown signal |
| Two consecutive green days holding above $47 | Bullish | Suggests $46.31 low held as support |
| Analyst upgrade or price-target raise | Bullish | Adds institutional bid; offsets technical weakness |
| Daily close below $44 on high volume | Bearish | Confirms deep breakdown; opens path to $40 |
| Volume dries up below 2M on any bounce | Bearish | Indicates lack of buyer interest; dead-cat bounce |
| Negative follow-up on earnings or guidance | Bearish | Extends selling pressure beyond today |
Bottom Line
Bottom line: AMRZAMRZ-- remains bearish as long as price stays below the $48.78 intraday high and the 52-week low at $46.31 fails to hold as support. A move above $48.78 on above-average volume would strengthen the setup and suggest a potential mean-reversion bounce, while a break below $44 would weaken the chart and open the door to a deeper breakdown toward $40.
Summary
- Amrize (AMRZ) fell 8.94 percent to $46.64, hitting a 52-week low of $46.31, on a Q2 earnings miss and EBITDA guidance cut, according to Yahoo Finance.
- Volume surged to 9.12M shares, nearly 3x the average, confirming institutional distribution on the selloff.
- Technical ratings are strong sell across daily, weekly, and monthly timeframes, with no momentum inflection in sight.
- Wall Street analysts maintain a mean price target of $61.83, implying roughly 33 percent upside -- but that view has not yet adjusted for the latest results.
- The $46.31 level is the critical test. A hold here could set up a bounce toward $48-$50. A break below opens a path to the $44-$45 derived zone.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Technical indicators can help frame risk and momentum, but they do not guarantee future price movement.
Everything leaves a footprint. The chart already knows.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet